Life Sciences Research Partners: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Life Sciences Research Partners
Largest movements
- Cash +€134,626
up €134,626 (+47.6%), from €282,554 to €417,180
mainly Current investments (+€92,966) and Receivables within one year (+€78,158)
No liability line moved by more than 1% of the balance sheet total.
- Financial income -€766,278
down €766,278 (-64.1%), from €1.2m to €429,902
- Staff costs +€79,792
up €79,792 (+23.2%), from €343,384 to €423,176
- Other operating charges -€71,979
down €71,979 (-60.6%), from €118,870 to €46,891
- Turnover +€47,191
up €47,191 (+14.9%), from €316,246 to €363,437
- Goods and materials -€42,371
down €42,371 (-41.6%), from €101,734 to €59,363
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €11,858,172 | €11,792,587 | -€65,585 | -0.6% |
| Fixed assets | 21/28 | €4,039,714 | €4,011,538 | -€28,176 | -0.7% |
| Tangible fixed assets | 22/27 | €102,538 | €74,362 | -€28,176 | -27.5% |
| Plant, machinery and equipment | 23 | €52,576 | €33,350 | -€19,226 | -36.6% |
| Furniture and vehicles | 24 | €49,962 | €41,012 | -€8,950 | -17.9% |
| Financial fixed assets | 28 | €3,937,176 | €3,937,176 | = | 0.0% |
| Companies linked by participating interests | 282/3 | €3,937,176 | €3,937,176 | = | 0.0% |
| Participating interests | 282 | €3,937,176 | €3,937,176 | = | 0.0% |
| Current assets | 29/58 | €7,818,458 | €7,781,049 | -€37,409 | -0.5% |
| Amounts receivable within one year | 40/41 | €85,755 | €7,597 | -€78,158 | -91.1% |
| Trade receivables | 40 | €85,690 | €7,532 | -€78,158 | -91.2% |
| Other amounts receivable | 41 | €65 | €65 | = | 0.0% |
| Current investments | 50/53 | €7,449,238 | €7,356,272 | -€92,966 | -1.2% |
| Cash at bank and in hand | 54/58 | €282,554 | €417,180 | +€134,626 | +47.6% |
| Deferred charges and accrued income | 490/1 | €911 | - | -€911 | |
| Total equity and liabilities | 10/49 | €11,858,172 | €11,792,587 | -€65,585 | -0.6% |
| Equity | 10/15 | €11,809,412 | €11,727,981 | -€81,431 | -0.7% |
| Reserves | 13 | €5,726,180 | €5,726,180 | = | 0.0% |
| Profit (loss) carried forward | 14 | €6,083,232 | €6,001,801 | -€81,431 | -1.3% |
| Amounts payable | 17/49 | €48,760 | €64,606 | +€15,846 | +32.5% |
| Amounts payable within one year | 42/48 | €48,760 | €52,373 | +€3,613 | +7.4% |
| Trade debts | 44 | €4,720 | €605 | -€4,115 | -87.2% |
| Suppliers | 440/4 | €4,720 | €605 | -€4,115 | -87.2% |
| Taxes, remuneration and social security | 45 | €44,040 | €51,768 | +€7,728 | +17.5% |
| Remuneration and social security | 454/9 | €44,040 | €51,768 | +€7,728 | +17.5% |
| Accrued charges and deferred income | 492/3 | - | €12,233 | +€12,233 | |
| Operating income | 70/76A | €342,758 | €388,906 | +€46,148 | +13.5% |
| Turnover | 70 | €316,246 | €363,437 | +€47,191 | +14.9% |
| Membership fees, donations, legacies and grants | 73 | - | €800 | +€800 | |
| Other operating income | 74 | €26,511 | €22,696 | -€3,815 | -14.4% |
| Non-recurring operating income | 76A | €1 | €1,973 | +€1,972 | +197,200% |
| Operating charges | 60/66A | €857,585 | €821,707 | -€35,878 | -4.2% |
| Goods for resale, raw materials and consumables | 60 | €101,734 | €59,363 | -€42,371 | -41.6% |
| Purchases | 600/8 | €101,734 | €59,363 | -€42,371 | -41.6% |
| Services and other goods | 61 | €247,450 | €256,540 | +€9,090 | +3.7% |
| Remuneration, social security and pensions | 62 | €343,384 | €423,176 | +€79,792 | +23.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €45,957 | €35,293 | -€10,664 | -23.2% |
| Other operating charges | 640/8 | €118,870 | €46,891 | -€71,979 | -60.6% |
| Non-recurring operating charges | 66A | €190 | €444 | +€254 | +134% |
| Operating profit (loss) | 9901 | -€514,827 | -€432,801 | +€82,026 | +15.9% |
| Financial income | 75/76B | €1,196,180 | €429,902 | -€766,278 | -64.1% |
| Recurring financial income | 75 | €1,196,180 | €429,902 | -€766,278 | -64.1% |
| Income from current assets | 751 | €303,495 | €59,339 | -€244,156 | -80.4% |
| Other financial income | 752/9 | €892,685 | €370,563 | -€522,122 | -58.5% |
| Financial charges | 65/66B | €110,982 | €78,532 | -€32,450 | -29.2% |
| Recurring financial charges | 65 | €110,982 | €78,532 | -€32,450 | -29.2% |
| Other financial charges | 652/9 | €110,982 | €78,532 | -€32,450 | -29.2% |
| Profit (loss) for the period before taxes | 9903 | €570,371 | -€81,431 | -€651,802 | |
| Profit (loss) for the period | 9904 | €570,371 | -€81,431 | -€651,802 | |
| Profit (loss) for the period to be appropriated | 9905 | €570,371 | -€81,431 | -€651,802 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.